Yousif Capital Management LLC Trims Stock Holdings in Sotera Health Company (NASDAQ:SHC)

Yousif Capital Management LLC cut its position in shares of Sotera Health Company (NASDAQ:SHC) by 2.3% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 54,130 shares of the company’s stock after selling 1,292 shares during the period. Yousif Capital Management LLC’s holdings in Sotera Health were worth $631,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the business. BNP Paribas Financial Markets acquired a new position in shares of Sotera Health in the 4th quarter valued at $208,000. Ananym Capital Management LP purchased a new stake in Sotera Health in the 4th quarter worth $13,680,000. Bank of Montreal Can raised its holdings in shares of Sotera Health by 10.6% during the fourth quarter. Bank of Montreal Can now owns 18,184 shares of the company’s stock valued at $249,000 after acquiring an additional 1,740 shares during the last quarter. Envestnet Portfolio Solutions Inc. raised its position in shares of Sotera Health by 17.3% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 15,839 shares of the company’s stock valued at $217,000 after buying an additional 2,340 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its position in Sotera Health by 45.1% during the fourth quarter. Bank of New York Mellon Corp now owns 1,630,736 shares of the company’s stock worth $22,308,000 after buying an additional 507,147 shares in the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Analyst Ratings Changes

SHC has been the topic of several recent analyst reports. Wall Street Zen lowered Sotera Health from a “buy” rating to a “hold” rating in a research note on Saturday, June 7th. The Goldman Sachs Group upgraded shares of Sotera Health from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $14.00 to $17.00 in a report on Monday, May 5th. Piper Sandler lowered their target price on shares of Sotera Health from $15.00 to $13.00 and set a “neutral” rating for the company in a research note on Wednesday, April 23rd. Finally, Barclays reduced their price target on shares of Sotera Health from $16.00 to $12.00 and set an “overweight” rating on the stock in a research note on Thursday, April 10th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, Sotera Health has an average rating of “Moderate Buy” and a consensus price target of $15.80.

Sotera Health Price Performance

Sotera Health stock opened at $11.39 on Friday. The firm has a market capitalization of $3.23 billion, a PE ratio of 142.39 and a beta of 1.87. Sotera Health Company has a 52 week low of $9.53 and a 52 week high of $17.08. The firm’s 50-day simple moving average is $11.93 and its 200 day simple moving average is $12.45. The company has a quick ratio of 2.19, a current ratio of 2.46 and a debt-to-equity ratio of 5.55.

Sotera Health (NASDAQ:SHC) last announced its earnings results on Thursday, May 1st. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.02. Sotera Health had a net margin of 2.24% and a return on equity of 41.08%. The firm had revenue of $254.52 million during the quarter, compared to the consensus estimate of $245.56 million. During the same quarter in the previous year, the company posted $0.13 EPS. The firm’s revenue for the quarter was up 2.6% on a year-over-year basis. On average, equities research analysts predict that Sotera Health Company will post 0.61 EPS for the current fiscal year.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.